Laguna Blends, Inc. (LAGBF) Harnessing the Benefits of Hemp
The Aesop fable The Swallow and the Other Birds, penned some 2,500 years ago, tells the story of how hemp…
Blog
Luvu Brands (LUVU) is “One to Watch”
Luvu Brands (OTCQB: LUVU) is a Georgia-based manufacturer that produces a range of products in the wellness, lifestyle, and casual…
eXp World Holdings, Inc. (EXPI) Real Estate Buyer/Seller Cloud Environment Offers Refreshing Alternative to Process Complexities
Agent-owned cloud brokerage firm eXp World Holdings, Inc. (OTCQB: EXPI) builds shareholder value by leveraging the use of cloud technology…
Momentous Entertainment Group (MMEG) Expanding its Content & Direct Marketing on Strength of Grounding in Faith-Centric & Sports Media
According to data put together recently by ZenithOptimedia, people these days spend a whopping 490 minutes per day (Latin America…
Moxian, Inc. (MOXC) Using Gamification to Boost Business Results
Moxian, Inc. (OTCQB: MOXC) is a multi-national company that is committed to building a comprehensive solution using promotional platforms and…
International Stem Cell Corp. (ISCO) Advancing Clinical Development Program for Parkinson’s Disease
International Stem Cell Corp. (OTCQB: ISCO) is a biotechnology company that works with parthenogenesis to treat diseases of the eyes,…
eXp World Holdings, Inc. (EXPI) CEO Scheduled to Speak at Mendix World in the Netherlands
Earlier today, eXp World Holdings, Inc. (OTCQB: EXPI) announced that Glenn Sanford, the company’s founder and chief executive officer, has…
The Marketers at Monaker Group (MKGI) show One Video is worth 10,000 Words
If a picture is worth a thousand words, what’s the value of a three-minute video like the Irish Experience Tour…
Alternet Systems, Inc. (ALYI) is a Fintech with a Future
The financial tech, or “fintech,” phenomenon is changing the landscape of financial services. Traditional ways of providing financial services such…
International Stem Cell Corp. (ISCO) Publishes Results from Preclinical Study of ISC-hpNSC® for Treatment of Parkinson’s Disease
Before the opening bell, International Stem Cell Corp. (OTCQB: ISCO) announced the publication of results from a 12-month preclinical, non-human…